cannabis indica

Anandamida (AEA)

termo de indexação original: Anandamide (AEA)

O que é Anandamida (AEA)

A anandamida, ou AEA, é um endocanabinoide: uma molécula produzida pelo próprio organismo que ativa os receptores canabinoides, os mesmos alvos do THC da planta. Foi o primeiro endocanabinoide identificado, em 1992, pelo grupo de Raphael Mechoulam na Universidade Hebraica de Jerusalém. O nome vem do sânscrito ananda, felicidade ou beatitude.

Quimicamente é uma amida do ácido araquidônico com etanolamina. Não fica estocada em vesículas como os neurotransmissores clássicos: é sintetizada sob demanda na membrana da célula, age ali perto e é rapidamente degradada pela enzima FAAH. Sobre o receptor CB1 comporta-se como agonista parcial — ativa, mas com menos intensidade que o THC, o que ajuda a explicar por que a anandamida endógena não produz os efeitos de uma dose de cannabis.

Aparece com frequência neste acervo porque boa parte da pesquisa sobre cannabis é, na verdade, pesquisa sobre o sistema que ela mobiliza. Estudos sobre apetite, dor, memória, ansiedade e resposta ao estresse recorrentemente medem níveis de anandamida ou manipulam sua degradação.

No acervo

O acervo do Cannabis Indica reúne 668 estudos científicos que tocam o composto Anandamida (AEA), publicados entre 1993 e 2024. Pela leitura automatizada, 531 (79%) foram classificados como favoráveis, 100 (15%) como inconclusivos e 37 (6%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (288 estudos), seguido de estudo em animais (170). As condições mais associadas são Inflamação, Ansiedade e Dor.

Estudos indexados
668
Período coberto
1993–2024
Favoráveis
531 · 79%
Inconclusivos
100 · 15%
Desfavoráveis
37 · 6%
Termo original
Anandamide (AEA)

O acervo em números

Tipo de estudo

Metanálise288
Estudo em Animais170
Estudo Laboratorial93
Ensaio Clínico67
Ensaio Clínico Duplo-Cego43
Metanálise Clínica7

Direção do resultado

Favorável531
Inconclusivo100
Desfavorável37

Por década

1990s11
2000s103
2010s277
2020s277

668 estudos

Filtrar e buscar no acervo →

Esta página mostra 301 dos 668 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity

    InconclusivoMetanáliseEndocanabinoide (não especificado)2-Araquidonoilglicerol (2-AG)+3
  2. 2024

    Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cocaína
  3. 2024

    Acute and Long-Term Effects of App-Delivered Heartfulness Meditation on Psychological Outcomes and the Endocannabinoid Signaling System in Cyclic Vomiting Syndrome

  4. 2024

    Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  5. 2024

    Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice

    FavorávelMetanáliseTetraidrocanabinol (THC)Endocanabinoide (não especificado)+9
  6. 2024

    Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTetraidrocanabinol (THC)Endocanabinoide (não especificado)+2
  7. 2024

    Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs

  8. 2024

    Neurolipidomic insights into anxiety disorders: Uncovering lipid dynamics for potential therapeutic advances

  9. 2024

    Nutrient composition of different energy-restricted diets determines plasma endocannabinoid profiles and adipose tissue DAGL-α expression; a 12-week randomized controlled trial in subjects with abdominal obesity

  10. 2024

    The circulating and central endocannabinoid system in obesity and weight loss

  11. 2023

    A systematic review of cannabidiol trials in neurodevelopmental disorders

  12. 2023

    Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease

  13. 2023

    Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis

    FavorávelMetanálise ClínicaInflamaçãoPsicose
  14. 2023

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

    FavorávelMetanáliseDisfunção CognitivaPsicoseEsquizofrenia+1
  15. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  16. 2023

    Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

  17. 2023

    Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3

  18. 2023

    CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

  19. 2023

    CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Hipertensão Arterial2-Araquidonoilglicerol (2-AG)
  20. 2023

    Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients

    FavorávelMetanáliseHemodiálise2-Araquidonoilglicerol (2-AG)
  21. 2023

    Could cannabinoids provide a new hope for ovarian cancer patients?

  22. 2023

    Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  23. 2023

    Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain

    FavorávelEnsaio ClínicoDorDor — Crônica2-Araquidonoilglicerol (2-AG)Acupuntura (MTC)
  24. 2023

    Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

  25. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  26. 2023

    Improved Anti-Biofilm Effect against the Oral Cariogenic Streptococcus mutans by Combined Triclosan/CBD Treatment

    FavorávelEstudo LaboratorialInflamaçãoInfecções BacterianasInfecções Fúngicas+2
  27. 2023

    Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder

  28. 2023

    Molecular Insights into GPCR Mechanisms for Drugs of Abuse

  29. 2023

    Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

    FavorávelMetanálise ClínicaDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+3
  30. 2023

    Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

  31. 2023

    Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies

  32. 2023

    Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior

  33. 2023

    Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans

  34. 2022

    (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders

  35. 2022

    A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

  36. 2022

    A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadePalmitoiletanolamida (PEA)+6
  37. 2022

    A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTranstornos de ComportamentoAutismo2-Araquidonoilglicerol (2-AG)+2
  38. 2022

    A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

  39. 2022

    A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System

  40. 2022

    Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration

  41. 2022

    Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone

  42. 2022

    Acute and long-term effects of cannabinoids on hypertension and kidney injury

  43. 2022

    Acute and long-term exercise differently modulate plasma levels of oxylipins, endocannabinoids, and their analogues in young sedentary adults: A sub-study and secondary analyses from the ACTIBATE randomized controlled-trial

  44. 2022

    Acute pancreatitis as a rare adverse event among cannabis users: A systematic review

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+17
  45. 2022

    Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDepressãoDisfunção CognitivaPsicosePalmitoiletanolamida (PEA)+4
  46. 2022

    Advanced Meditation and Vegan Diet Increased Acylglycines and Reduced Lipids Associated with Improved Health: A Prospective Longitudinal Study

  47. 2022

    Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats

  48. 2022

    Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1

  49. 2022

    Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects

  50. 2022

    Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — Melanoma
  51. 2022

    Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

  52. 2022

    Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadeCanabinoide Sintético (não especificado)
  53. 2022

    Cannabidiol in the context of substance use disorder treatment: A systematic review

  54. 2022

    Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study

  55. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  56. 2022

    Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection

  57. 2022

    Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

  58. 2022

    Cannabinoids in rheumatology: Friend, foe or a bystander?

  59. 2022

    Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

  60. 2022

    Cannabinoids: Therapeutic Use in Clinical Practice

  61. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  62. 2022

    Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review

  63. 2022

    Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2

    DesfavorávelEstudo em AnimaisCâncerCâncer — CólonCâncer — Melanoma
  64. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  65. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

  66. 2022

    Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences

  67. 2022

    Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

  68. 2022

    Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study

    DesfavorávelMetanáliseDiabetesGestação2-Araquidonoilglicerol (2-AG)
  69. 2022

    Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort

    InconclusivoEnsaio ClínicoTEPTEndocanabinoide (não especificado)2-Araquidonoilglicerol (2-AG)+1
  70. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  71. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

    FavorávelMetanáliseDorInflamaçãoAnsiedadePalmitoiletanolamida (PEA)+17
  72. 2022

    Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence

  73. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  74. 2022

    Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model

  75. 2022

    Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions

    InconclusivoMetanáliseDorAnsiedadeDor — AgudaExercício Físico
  76. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  77. 2022

    Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis

  78. 2022

    Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress

  79. 2022

    Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study

  80. 2022

    Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  81. 2022

    Effects of Omega-3 Supplementation on Components of the Endocannabinoid System and Metabolic and Inflammatory Responses in Adipose and Liver of Peripartum Dairy Cows

    InconclusivoEstudo em AnimaisInflamaçãoObesidadeOutros Compostos RelacionadosÔmega-3
  82. 2022

    Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes

  83. 2022

    Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)Endocanabinoide (não especificado)+3
  84. 2022

    Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption

  85. 2022

    Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

  86. 2022

    Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

  87. 2022

    Endocannabinoid signaling in glioma

  88. 2022

    Endocannabinoid System in Polycystic Kidney Disease

  89. 2022

    Exercise-induced increases in Anandamide and BDNF during extinction consolidation contribute to reduced threat following reinstatement: Preliminary evidence from a randomized controlled trial

    FavorávelEnsaio ClínicoTEPT2-Araquidonoilglicerol (2-AG)Exercício Físico
  90. 2022

    Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota

  91. 2022

    Expression and Functions of the CB 2 Receptor in Human Leukocytes

  92. 2022

    FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain

  93. 2022

    Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury

  94. 2022

    Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice

  95. 2022

    Footshock-Induced Abstinence from Compulsive Methamphetamine Self-administration in Rat Model Is Accompanied by Increased Hippocampal Expression of Cannabinoid Receptors (CB1 and CB2)

  96. 2022

    Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice

  97. 2022

    Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults

  98. 2022

    Higher trait neuroticism is associated with greater fatty acid amide hydrolase binding in borderline and antisocial personality disorders

  99. 2022

    Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  100. 2022

    In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction

  101. 2022

    In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils

  102. 2022

    Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study

  103. 2022

    Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

  104. 2022

    Inhibition of anandamide hydrolysis does not rescue respiratory abnormalities observed in an animal model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoide Sintético (não especificado)
  105. 2022

    Investigation of the Effects of the Endogenous Cannabinoid Anandamide on Luminal A Breast Cancer Cell Line MCF-7

    FavorávelEstudo LaboratorialCâncerCâncer — MamaEndocanabinoide (não especificado)
  106. 2022

    Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies

  107. 2022

    Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies

    DesfavorávelMetanáliseDorCâncerInflamaçãoTHC FarmacêuticoTHC:CBD Farmacêutico+14
  108. 2022

    Memory Consolidation Depends on Endogenous Hippocampal Levels of Anandamide: CB1 and M4, but Possibly not TRPV1 Receptors Mediate AM404 effects

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-x
  109. 2022

    Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence

  110. 2022

    Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies

  111. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  112. 2022

    Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

  113. 2022

    Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  114. 2022

    Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved

    FavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Aterosclerose
  115. 2022

    Role of cannabis in inflammatory bowel diseases

  116. 2022

    Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

  117. 2022

    Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations

  118. 2022

    Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

  119. 2022

    Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  120. 2022

    Targeting the Achilles’ Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide

    FavorávelEstudo LaboratorialInfecções Bacterianas
  121. 2022

    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

  122. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  123. 2022

    Targeting the Endocannabinoidome in Pancreatic Cancer

  124. 2022

    Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report

  125. 2022

    The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System

  126. 2022

    The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study

  127. 2022

    The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers-A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — AgudaPalmitoiletanolamida (PEA)
  128. 2022

    The effects of acute alcohol administration on circulating endocannabinoid levels in humans

  129. 2022

    The endocannabinoid anandamide is an airway relaxant in health and disease

    FavorávelEstudo em AnimaisAsmaDPOC
  130. 2022

    The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders

  131. 2022

    The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety

  132. 2022

    The endocannabinoids anandamide and 2-arachidonoylglycerol modulate the expression of angiogenic factors on HTR8/SVneo placental cells

  133. 2022

    The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer

  134. 2022

    The role of the cannabinoid system in fear memory and extinction in male and female mice

  135. 2022

    The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy

    FavorávelEstudo em AnimaisEpilepsia
  136. 2022

    Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation

  137. 2022

    Tonic endocannabinoid signaling supports sleep through development in both sexes

  138. 2022

    Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?

  139. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  140. 2022

    Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

  141. 2021

    A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery

  142. 2021

    Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus

    FavorávelEstudo LaboratorialInfecções BacterianasInfecção por Estafilococos
  143. 2021

    Anandamide Exerts a Differential Effect on Human Placenta Before and After the Onset of Labor

    InconclusivoEstudo LaboratorialGestação
  144. 2021

    Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes

  145. 2021

    Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase

  146. 2021

    Brain imaging of cannabinoid type I (CB1 ) receptors in women with cannabis use disorder and male and female healthy controls

  147. 2021

    Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

  148. 2021

    Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofrenia
  149. 2021

    Cannabidiol and Neurodevelopmental Disorders in Children

  150. 2021

    Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do SonoTEPT
  151. 2021

    Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaInflamaçãoDependência — Cannabis+9
  152. 2021

    Cannabigerol and cannabichromene in Cannabis sativa L.

  153. 2021

    Cannabinoid control of hippocampal functions: the where matters

  154. 2021

    Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

  155. 2021

    Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review

  156. 2021

    Cannabinoids for skin diseases and hair regrowth

  157. 2021

    Cannabinoids modulate food preference and consumption in Drosophila melanogaster

  158. 2021

    Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension

  159. 2021

    Cannabis and Autoimmunity: Possible Mechanisms of Action

  160. 2021

    Cannabis and Inflammation in HIV: A Review of Human and Animal Studies

  161. 2021

    Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

  162. 2021

    CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoFibroseEndocanabinoide (não especificado)+3
  163. 2021

    CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder

    FavorávelEstudo LaboratorialDorInflamaçãoCistiteEndocanabinoide (não especificado)
  164. 2021

    Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol

  165. 2021

    Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine

    FavorávelEstudo em AnimaisEnxaquecaHidrolase de Amidas de Ácidos Graxos (FAAH)
  166. 2021

    Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors

  167. 2021

    Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study

    InconclusivoEstudo em AnimaisAplicações Veterinárias2-Araquidonoilglicerol (2-AG)
  168. 2021

    Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity

  169. 2021

    Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase

  170. 2021

    Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels

  171. 2021

    Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review

  172. 2021

    Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+3
  173. 2021

    Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids

  174. 2021

    Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping

    InconclusivoMetanáliseGestação2-Araquidonoilglicerol (2-AG)
  175. 2021

    Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster)

    InconclusivoEstudo em AnimaisAnsiedade
  176. 2021

    Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

  177. 2021

    Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies

    InconclusivoMetanálise ClínicaAutismo2-Araquidonoilglicerol (2-AG)
  178. 2021

    Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study

  179. 2021

    Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review

  180. 2021

    Endocannabinoid-mediated synaptic plasticity and substance use disorders

  181. 2021

    Endocannabinoids and Heart Rate Variability Alterations after Exposure to Prolonged Intensive Physical Exercise of the Hellenic Navy SEALs

  182. 2021

    Endocannabinoids increase human adipose stem cell differentiation and growth factor secretion in vitro

    FavorávelEstudo Laboratorial2-Araquidonoilglicerol (2-AG)
  183. 2021

    Endocannabinoids, cannabinoids and the regulation of anxiety

    InconclusivoMetanáliseAnsiedade
  184. 2021

    Endogenous anandamide and self-reported pain are significantly reduced after a 2-week multimodal treatment with and without radon therapy in patients with knee osteoarthritis: a pilot study

    InconclusivoEnsaio ClínicoArtriteArtrite — Osteoartrite
  185. 2021

    Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans

    FavorávelMetanáliseAnsiedade2-Araquidonoilglicerol (2-AG)
  186. 2021

    Experimental therapies in Irritable Bowel Syndrome

  187. 2021

    Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment

    InconclusivoMetanáliseEpilepsia
  188. 2021

    Fear extinction learning and anandamide: an fMRI study in healthy humans

    FavorávelMetanáliseAnsiedadeTEPT
  189. 2021

    From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia

  190. 2021

    Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice

  191. 2021

    Gut barrier and microbiota changes with glycine and branched-chain amino acid supplementation in chronic haemodialysis patients

  192. 2021

    Hair endocannabinoid concentrations in individuals with acute and weight-recovered anorexia nervosa

  193. 2021

    Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study

    FavorávelEstudo LaboratorialCâncerCâncer — Boca2-Araquidonoilglicerol (2-AG)
  194. 2021

    Impact of saffron (Crocus Sativus Linn) supplementation and resistance training on markers implicated in depression and happiness levels in untrained young males

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoHidrolase de Amidas de Ácidos Graxos (FAAH)
  195. 2021

    Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications

  196. 2021

    Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models

  197. 2021

    Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation

  198. 2021

    Metabolic Consequences of Gestational Cannabinoid Exposure

  199. 2021

    Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study

  200. 2021

    Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão2-Araquidonoilglicerol (2-AG)+2
  201. 2021

    New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence

  202. 2021

    Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases

  203. 2021

    Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

  204. 2021

    Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis

    FavorávelMetanálisePsicoseEsquizofrenia2-Araquidonoilglicerol (2-AG)
  205. 2021

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  206. 2021

    Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats

  207. 2021

    Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia

  208. 2021

    Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients

  209. 2021

    Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  210. 2021

    Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat

  211. 2021

    Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoHidrolase de Amidas de Ácidos Graxos (FAAH)
  212. 2021

    Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity

    InconclusivoMetanáliseEsteatose Hepática
  213. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  214. 2021

    Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

  215. 2021

    Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels

    DesfavorávelEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Canabicromeno (CBC)+5
  216. 2021

    THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroEndocanabinoide (não especificado)
  217. 2021

    The antimicrobial effect behind Cannabis sativa

    FavorávelMetanáliseInfecções BacterianasCanabigerol (CBG)Canabinol (CBN)+5
  218. 2021

    The cannabinoid system and microglia in health and disease

    FavorávelMetanáliseDorInflamaçãoAnsiedade2-Araquidonoilglicerol (2-AG)+8
  219. 2021

    The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

  220. 2021

    The Current and Potential Application of Medicinal Cannabis Products in Dentistry

  221. 2021

    The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial

  222. 2021

    The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways

    FavorávelEstudo em AnimaisEstresseSíndrome do Desconforto Respiratório Agudo
  223. 2021

    The endocannabinoid system - current implications for drug development

  224. 2021

    The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health

  225. 2021

    The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD

  226. 2021

    The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells

    FavorávelEstudo LaboratorialInfertilidade Feminina
  227. 2021

    The rise and fall of anandamide: processes that control synthesis, degradation, and storage

    FavorávelMetanálise
  228. 2021

    The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?

  229. 2021

    The role of endocannabinoids in pregnancy

  230. 2021

    The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease

  231. 2021

    Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER + breast cancer cells: Impact on aromatase and steroid receptors

    FavorávelEstudo LaboratorialCâncerCâncer — MamaTetraidrocanabinol (THC)
  232. 2021

    URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors

    FavorávelEstudo LaboratorialExcitotoxicidadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  233. 2020

    A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing

  234. 2020

    A Potential Involvement of Anandamide in the Modulation of HO/NOS Systems: Women, Menopause, and “Medical Cannabinoids”

  235. 2020

    A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDisfunção CognitivaPsicose+1
  236. 2020

    Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases: A pilot study

  237. 2020

    Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain

  238. 2020

    Anandamide Metabolites Protect against Seizures through the TRP Channel Water Witch in Drosophila melanogaster

    FavorávelEstudo em AnimaisEpilepsia2-Araquidonoilglicerol (2-AG)
  239. 2020

    Anandamide prevents the adhesion of filamentous Candida albicans to cervical epithelial cells

    FavorávelEstudo LaboratorialInfecções Fúngicas
  240. 2020

    Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial

  241. 2020

    Associating Emergency Medical Services personnel's workload, trauma exposure, and health with the cortisol, endocannabinoid, and N-acylethanolamine concentrations in their hair

  242. 2020

    Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures

    InconclusivoEstudo em AnimaisEpilepsia
  243. 2020

    Beyond THC and Endocannabinoids

  244. 2020

    Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

  245. 2020

    Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de Parkinson
  246. 2020

    Cannabidiol Oil-Associated Microscopic Colitis

  247. 2020

    Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ 1-42 peptide in rat hippocampal neurons

  248. 2020

    Cannabinoids and Cannabinoid Receptors: The Story so Far

    InconclusivoMetanálise2-Araquidonoilglicerol (2-AG)Canabigerol (CBG)+5
  249. 2020

    Cannabinoids and Chronic Liver Diseases

  250. 2020

    Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment

    FavorávelMetanáliseCâncerCâncer — Mama
  251. 2020

    Cannabinoids, Endocannabinoids and Sleep

  252. 2020

    Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome

  253. 2020

    Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats With Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism

  254. 2020

    Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling

    FavorávelEstudo em AnimaisAnsiedadeInfecções FúngicasDistoniaMicrobioma
  255. 2020

    Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat

  256. 2020

    Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial

  257. 2020

    Effects of the monoacylglycerol lipase inhibitor JZL184 on chickens infected with avian pathogenic Escherichia coli O78: A preliminary pharmacokinetic and infection study

  258. 2020

    Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders

    FavorávelMetanáliseEpilepsia2-Araquidonoilglicerol (2-AG)
  259. 2020

    Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids

  260. 2020

    Endocannabinoids and Stroke Prevention: Review of Clinical Studies

    FavorávelMetanálise ClínicaAVC2-Araquidonoilglicerol (2-AG)
  261. 2020

    GPR119 Is a Potent Regulator of Human Sebocyte Biology

  262. 2020

    Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity

  263. 2020

    Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women

  264. 2020

    Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia

  265. 2020

    Inner Engineering Practices and Advanced 4-day Isha Yoga Retreat Are Associated with Cannabimimetic Effects with Increased Endocannabinoids and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators

  266. 2020

    Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

  267. 2020

    N-Acylphosphatidylethanolamines and N-acylethanolamines increase in saliva upon food mastication: the influence of the individual nutritional status and fat type in food

  268. 2020

    Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy

  269. 2020

    Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDoenças Cardiovasculares (DCV)Estresse OxidativoOleoiletanolamida (OEA)+6
  270. 2020

    Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus

    FavorávelEstudo LaboratorialInfecções BacterianasInfecção por Estafilococos
  271. 2020

    Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior

  272. 2020

    Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise

  273. 2020

    Serum endocannabinoid levels in suicide attempters: A pilot study

    InconclusivoMetanáliseTentativa de SuicídioOutros Compostos Relacionados
  274. 2020

    THC Regulates Tearing via Cannabinoid CB1 Receptors

  275. 2020

    The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

  276. 2020

    The Endocannabinoid System May Modulate Sleep Disorders in Aging

  277. 2020

    Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet

    FavorávelEnsaio Clínico Duplo-CegoCâncerInflamaçãoDoenças Cardiovasculares (DCV)2-Araquidonoilglicerol (2-AG)+8
  278. 2019

    Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients: A Randomized Controlled Clinical Trial

    FavorávelEnsaio ClínicoEnxaquecaExercício Físico
  279. 2019

    Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor

    FavorávelEstudo em AnimaisTraumatismo Cranioencefálico
  280. 2019

    Cannabinoid Regulation of Fear and Anxiety: an Update

  281. 2019

    Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

  282. 2019

    Cannabinoids and bone regeneration

  283. 2019

    Cannabinoids and Dementia: A Review of Clinical and Preclinical Data

  284. 2019

    Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease

  285. 2019

    Endocannabinoid System Components as Potential Biomarkers in Psychiatry

  286. 2019

    Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis

  287. 2019

    Fatty Acid Amide Hydrolase Inhibition Normalises Bladder Function and Reduces Pain Through Normalising the Anandamide/Palmitoylethanolamine Ratio in the Inflamed Bladder of Rats

  288. 2019

    Food database of N-acyl-phosphatidylethanolamines, N-acylethanolamines and endocannabinoids and daily intake from a Western, a Mediterranean and a vegetarian diet

    InconclusivoEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Outros Compostos Relacionados+1
  289. 2019

    Future Aspects for Cannabinoids in Breast Cancer Therapy

  290. 2019

    Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.

  291. 2019

    Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa

    InconclusivoEstudo em AnimaisAnorexia Nervosa2-Araquidonoilglicerol (2-AG)
  292. 2019

    Interferon γ Treatment Increases Endocannabinoid and Related N-acylethanolamine Levels in T84 Human Colon Carcinoma Cells

    InconclusivoEstudo LaboratorialCâncerCâncer — Cólon2-Araquidonoilglicerol (2-AG)
  293. 2019

    Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome

  294. 2019

    Lower circulating endocannabinoid levels in children with autism spectrum disorder

  295. 2019

    Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer

  296. 2019

    Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity

  297. 2019

    Opposite roles of cannabinoid receptor 1 and 2 in hepatocarcinogenesis

  298. 2019

    Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

  299. 2019

    Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study

    FavorávelMetanáliseEnxaquecaHidrolase de Amidas de Ácidos Graxos (FAAH)
  300. 2019

    Plants come to mind: phytocannabinoids, endocannabinoids and the control of seizures

  301. 2018

    An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers

    FavorávelMetanálise

Continue por aqui

Perguntas frequentes

Quantos estudos sobre anandamida (aea) estão indexados no acervo?
São 668 estudos, publicados entre 1993 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 288 · Estudo em Animais: 170 · Estudo Laboratorial: 93 · Ensaio Clínico: 67 · Ensaio Clínico Duplo-Cego: 43 · Metanálise Clínica: 7. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 531 favoráveis, 100 inconclusivos e 37 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Anandamida (AEA) — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/anandamida-aea/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Anandamida (AEA) — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/anandamida-aea/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.